Evidence map›Paper›PMID 42646154›Full record

ReviewJournal of fungi (Basel, Switzerland)2026

Prophylaxis Regimens for

Xiaojing Wu, Yue Zhang, Keming Wang, Liuluan Zhu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaojing WuBeijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yue ZhangBeijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.ORCID 0000-0002-5826-5621
Keming WangBeijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Liuluan ZhuBeijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Funding

Beijing High-Level Innovation and Entrepreneurship Talent Support Program Young Top Talent Projects G202522157Beijing High-Level Public Health Technical Talent Training Program Discipline Backbone Talent 02-32National Natural Science Foundation of China 82372189National Natural Science Foundation of China 82471783the Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project 2025ZD01905200
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

non-HIV immunocompromised patientsPneumocystis jirovecii pneumoniaprophylaxistrimethoprim-sulfamethoxazole

Identifiers

PMID42646154
PMCPMC13514556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.